Researchers have created a new vaccine candidate to treat staph and antibiotic-resistant MRSA infections. In mouse studies, the new candidate offered high immunity to otherwise lethal levels of Staphylococcus aureus, or staph, and methicillin-resistant S. aureus, or MRSA.
